---
figid: PMC8231946__cancers-13-02969-g002a
figtitle: Proliferation, dissemination and proteasome inhibitor resistance
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8231946
filename: cancers-13-02969-g002a.jpg
figlink: .na.character
number: F2a
caption: 'Mutual transfer of different molecules contained in extracellular vesicle
  (EV) cargo between multiple myeloma cell-derived EVs (MM-EVs) and bone marrow mesenchymal
  stem cell (BM-MSC)-derived EVs (MSC-EVs). (A) MM-EVs contribute to osteoclast (OCL)
  precursor (OCP) migration, survival, differentiation, and osteolysis. MM-EVs also
  inhibit osteoblast differentiation, either directly or by stimulating BM-MSCs. PI:
  proteasome inhibitor; MM: multiple myeloma; lnc: long noncoding; AS: antisense;
  MM-EVs: multiple myeloma cell-derived extracellular vesicles; IL: interleukin; AREG:
  amphiregulin; MSCs: mesenchymal stem cells; RANKL: receptor activator of nuclear
  factor-κB ligand; MØ: macrophage; TNFα: tumor necrosis factor-α; OCP: osteoclast
  precursors; CXCR4: C-X-C chemokine receptor type 4; DKK-1: Dickkopf-1; OPG: osteoprotegerin;
  TRAP: tartrate-resistant acid phosphatase; BCLXL: B-cell lymphoma-extra large; p-AKT:
  phosphorylated protein kinase B; CTSK: cathepsin K; MMP-9: matrix metalloprotease-9;
  OCL: osteoclast. (B) Interaction between myeloma cells and their microenvironment
  through EVs containing PIWI-interacting RNAs (piRNAs), long noncoding RNAs (lncRNAs),
  and proteins, contributing to angiogenesis, MDSC proliferation, and cancer-associated
  fibroblast (CAF) transformation of MSCs. VEGF: vascular endothelial growth factor;
  IL: ICAM-1: interleukin; intercellular adhesion molecule-1; ECs: endothelial cells;
  piRNA: P-Element induced wimpy testis (PIWI)-interacting RNA; miR: microRNA; MM:
  multiple myeloma; CCL2: C-C motif chemokine 2; p-FAK, phospho-focal adhesion kinase;
  CAF: cancer associated fibroblast; MSC-EVs: mesenchymal stromal cell-derived extracellular
  vesicles; PSMA3: proteasome 20S subunit alpha 3; MSCs: mesenchymal stem cells; MDSCs;
  myeloid-derived suppressor cells; MM-EVs: multiple myeloma-derived extracellular
  vesicles; iNOS: inducible nitric oxidase synthase; TRAP: tartrate-resistant acid
  phosphatase; OCL: osteoclast.'
papertitle: 'Realization of Osteolysis, Angiogenesis, Immunosuppression, and Drug
  Resistance by Extracellular Vesicles: Roles of RNAs and Proteins in Their Cargoes
  and of Ectonucleotidases of the Immunosuppressive Adenosinergic Noncanonical Pathway
  in the Bone Marrow Niche of Multiple Myeloma.'
reftext: Takashi Watanabe. Cancers (Basel). 2021 Jun;13(12):2969.
year: '2021'
doi: 10.3390/cancers13122969
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: multiple myeloma | isatuximab | daratumumab | mesenchymal stem cells | osteoclasts
  | ectoenzyme | CD38 | extracellular vesicle | exosome | microRNA | long noncoding
  RNA | PIWI-interacting RNA
automl_pathway: 0.9338906
figid_alias: PMC8231946__F2a
figtype: Figure
redirect_from: /figures/PMC8231946__F2a
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8231946__cancers-13-02969-g002a.html
  '@type': Dataset
  description: 'Mutual transfer of different molecules contained in extracellular
    vesicle (EV) cargo between multiple myeloma cell-derived EVs (MM-EVs) and bone
    marrow mesenchymal stem cell (BM-MSC)-derived EVs (MSC-EVs). (A) MM-EVs contribute
    to osteoclast (OCL) precursor (OCP) migration, survival, differentiation, and
    osteolysis. MM-EVs also inhibit osteoblast differentiation, either directly or
    by stimulating BM-MSCs. PI: proteasome inhibitor; MM: multiple myeloma; lnc: long
    noncoding; AS: antisense; MM-EVs: multiple myeloma cell-derived extracellular
    vesicles; IL: interleukin; AREG: amphiregulin; MSCs: mesenchymal stem cells; RANKL:
    receptor activator of nuclear factor-κB ligand; MØ: macrophage; TNFα: tumor necrosis
    factor-α; OCP: osteoclast precursors; CXCR4: C-X-C chemokine receptor type 4;
    DKK-1: Dickkopf-1; OPG: osteoprotegerin; TRAP: tartrate-resistant acid phosphatase;
    BCLXL: B-cell lymphoma-extra large; p-AKT: phosphorylated protein kinase B; CTSK:
    cathepsin K; MMP-9: matrix metalloprotease-9; OCL: osteoclast. (B) Interaction
    between myeloma cells and their microenvironment through EVs containing PIWI-interacting
    RNAs (piRNAs), long noncoding RNAs (lncRNAs), and proteins, contributing to angiogenesis,
    MDSC proliferation, and cancer-associated fibroblast (CAF) transformation of MSCs.
    VEGF: vascular endothelial growth factor; IL: ICAM-1: interleukin; intercellular
    adhesion molecule-1; ECs: endothelial cells; piRNA: P-Element induced wimpy testis
    (PIWI)-interacting RNA; miR: microRNA; MM: multiple myeloma; CCL2: C-C motif chemokine
    2; p-FAK, phospho-focal adhesion kinase; CAF: cancer associated fibroblast; MSC-EVs:
    mesenchymal stromal cell-derived extracellular vesicles; PSMA3: proteasome 20S
    subunit alpha 3; MSCs: mesenchymal stem cells; MDSCs; myeloid-derived suppressor
    cells; MM-EVs: multiple myeloma-derived extracellular vesicles; iNOS: inducible
    nitric oxidase synthase; TRAP: tartrate-resistant acid phosphatase; OCL: osteoclast.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - CXCR4
  - FLT3
  - ITGAM
  - CD38
  - DKK1
  - TRAP
  - ACP5
  - CD40LG
  - TRAF2
  - TRRAP
  - TDRD7
  - SCYL1
  - AREG
  - CXCL8
  - TNFSF11
  - AKT1
  - AKT2
  - AKT3
  - BTF3P11
  - TNFRSF11B
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - PPBP
---
